$CTXR
Citius Pharmaceuticals Inc. Common
XNAS
Why is CTXR up today? It is at $0.600 (+0.03%), and our scanner flagged it 19 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CTXR spikes, and full due diligence on CTXR — key stats, earnings, dilution and insider activity. Free.
Get free $CTXR alerts the moment volume spikes
Our scanner flagged $CTXR 19 times in the last 30 days. Create a free account to track $CTXR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.600
- Change today
- +0.03%
- Previous close
- $0.600
- 52-week range
- $0.469 – $2.19
- Market cap
- $16M
- Institutional own.
- 5.68%
- Total held
- 9.9%
- Tradeable float
- 24.7M 90% of shares · after 4% insiders + 6% institutions
- Short interest
- 5.2M ▲ +4% vs prior · as of 2026-07-31
- Short % of float
- 20.8%
- Days to cover
- 8.3d
- Avg daily volume
- 738K
- Exchange
- XNAS
- 5mthin
- 750x
- 15mthin
- 750x
- 1hthin
- 6.9x
- 1D
- --
Get free CTXR + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CTXR moving today?
Here is the latest on CTXR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTXR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $CTXR runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 10,507,616 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $250.0M in size · Priced at $0.985/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CTXR Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CTXR Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
CTXR stock FAQ
Why is $CTXR moving today?
Here is the latest on CTXR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTXR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the CTXR stock price today?
CTXR last traded at $0.600, up 0.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CTXR alerts?
The CTXR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CTXR 19 times in the last 30 days.
What exchange is CTXR on?
CTXR (Citius Pharmaceuticals Inc. Common) trades on XNAS, with a market cap of about $16M.
Is CTXR good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CTXR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.